Soleno Therapeutics
SLNO
SLNO
23 hedge funds and large institutions have $21.8M invested in Soleno Therapeutics in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 8 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
63% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 8
Holders
23
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$9.47M | |
| 2 | +$94.8K | |
| 3 | +$3.43K | |
| 4 |
VAG
VisionPoint Advisory Group
Dallas,
Texas
|
+$721 |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$64 |
Top Sellers
| 1 | -$638K | |
| 2 | -$303K | |
| 3 | -$250K | |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$212K |
| 5 |
CP
Clayton Partners
Berkeley,
California
|
-$199K |